BTL-II proteins
US7244822B2 · kind B2 · utility
1Cited by
1References
26Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 19, 2003 |
| Grant date | Jul 17, 2007 |
| Priority date | — |
| Expiry date | Dec 23, 2023 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2319/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention provides isolated BTL-II proteins, nucleic acids, antibodies, antagonists, and agonists and methods of making and using the same. Diagnostic, screening, and therapeutic methods using the compositions of the invention are provided. For example, the compositions of the invention can be used for diagnosis and treatment of inflammatory bowel diseases and for enhancing a mucosal immune response to an antigen.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.